| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 3e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 4e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |